Round Rock Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Hold
10,690
– – 0.03% 286
2026
Q2
$387K Hold
10,690
– – 0.05% 245
2026
Q1
$354K Hold
10,690
– – 0.05% 237
2025
Q4
$495K Buy
10,690
+4,008
+60% +$168K 0.07% 195
2025
Q3
$237K Buy
+6,682
New +$232K 0.04% 285

Other funds holding COLL

Round Rock Advisors's COLL Position: Q3 2026 in Review

Round Rock Advisors held its Collegium Pharmaceutical (COLL) position steady in Q3 2026 at 10,690 shares worth $233K. The position accounts for 0.03% of the portfolio, ranked #286.

Round Rock Advisors first reported a position in COLL in Q3 2025 and has held it in 5 quarters since. The position peaked at $495K in Q4 2025. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Round Rock Advisors held 10,690 shares of Collegium Pharmaceutical worth $233K as of Q3 2026.
  • Round Rock Advisors left its Collegium Pharmaceutical share count unchanged in Q3 2026.
  • Collegium Pharmaceutical made up 0.03% of Round Rock Advisors's portfolio in Q3 2026, its #286 holding.
  • Round Rock Advisors first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 5 quarters since.
  • Round Rock Advisors's Collegium Pharmaceutical position peaked at $495K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Round Rock Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.